NASDAQ:KLRA | Free Cash Flow | Kailera Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$68.31M
2025-03-31-$18.2M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income